Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Net Margin (2021 - 2025)

Historic Net Margin for Pulse Biosciences (PLSE) over the last 3 years, with Q3 2025 value amounting to 22518.6%.

  • Pulse Biosciences' Net Margin changed N/A to 22518.6% in Q3 2025 from the same period last year, while for Sep 2025 it was 86876.74%, marking a year-over-year change of. This contributed to the annual value of 8357.86% for FY2022, which is 38684400.0% down from last year.
  • Latest data reveals that Pulse Biosciences reported Net Margin of 22518.6% as of Q3 2025.
  • Pulse Biosciences' Net Margin's 5-year high stood at 102188.89% during Q4 2022, with a 5-year trough of 22518.6% in Q3 2025.
  • For the 3-year period, Pulse Biosciences' Net Margin averaged around 11133.32%, with its median value being 3189.23% (2021).
  • Within the past 5 years, the most significant YoY rise in Pulse Biosciences' Net Margin was 1040154300bps (2022), while the steepest drop was 1040154300bps (2022).
  • Over the past 3 years, Pulse Biosciences' Net Margin (Quarter) stood at 1826.54% in 2021, then soared by 5695bps to 102188.89% in 2022, then plummeted by -122bps to 22518.6% in 2025.
  • Its Net Margin was 22518.6% in Q3 2025, compared to 102188.89% in Q4 2022 and 4665.33% in Q2 2022.